Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10566236rdf:typepubmed:Citationlld:pubmed
pubmed-article:10566236lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:10566236lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:10566236lifeskim:mentionsumls-concept:C0003448lld:lifeskim
pubmed-article:10566236lifeskim:mentionsumls-concept:C0019398lld:lifeskim
pubmed-article:10566236lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:10566236lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:10566236lifeskim:mentionsumls-concept:C0725066lld:lifeskim
pubmed-article:10566236pubmed:issue4lld:pubmed
pubmed-article:10566236pubmed:dateCreated1999-12-7lld:pubmed
pubmed-article:10566236pubmed:abstractTextTuberculosis and other mycobacterial diseases are considered at present to be one of the prominent problems of health services. Since 1985, and in particular in the 1990s, a search for new structures of antimycobacterial drugs is one of the first and foremost fields of chemotherapeutic research. The present review paper surveys the studies carried out in the field of five-membered heterocyclic compounds containing one species of the heteroatom (furan, thiophene, pyrrol, diazoles, triazoles, tetrazoles, indol, carbazol, and other more complex cyclic compounds of nitrogen and sulfur) since 1984, making use of the journal Chemical Abstracts and original papers.lld:pubmed
pubmed-article:10566236pubmed:languageczelld:pubmed
pubmed-article:10566236pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10566236pubmed:citationSubsetIMlld:pubmed
pubmed-article:10566236pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10566236pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10566236pubmed:statusMEDLINElld:pubmed
pubmed-article:10566236pubmed:monthJullld:pubmed
pubmed-article:10566236pubmed:issn1210-7816lld:pubmed
pubmed-article:10566236pubmed:authorpubmed-author:WaisserKKlld:pubmed
pubmed-article:10566236pubmed:authorpubmed-author:DrhováLLlld:pubmed
pubmed-article:10566236pubmed:issnTypePrintlld:pubmed
pubmed-article:10566236pubmed:volume48lld:pubmed
pubmed-article:10566236pubmed:ownerNLMlld:pubmed
pubmed-article:10566236pubmed:authorsCompleteYlld:pubmed
pubmed-article:10566236pubmed:pagination147-55lld:pubmed
pubmed-article:10566236pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10566236pubmed:meshHeadingpubmed-meshheading:10566236...lld:pubmed
pubmed-article:10566236pubmed:meshHeadingpubmed-meshheading:10566236...lld:pubmed
pubmed-article:10566236pubmed:year1999lld:pubmed
pubmed-article:10566236pubmed:articleTitle[Advances in the development of new antitubercular agents from a group of 5-membered heterocyclic compounds containing one type of heteroatom].lld:pubmed
pubmed-article:10566236pubmed:affiliationKatedra anorganické a organické chemie Farmaceutické fakulty Univerzity Karlovy, Hradec Králové.lld:pubmed
pubmed-article:10566236pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10566236pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:10566236pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed